PatientsVille.com LogoPatientsVille.com

Diarrhea Predominant Irritable Bowel Syndrome | The Effects of Soy Dietary Fiber in Adults With Diarrhea Predominant Irritable Bowel Syndrome

Diarrhea Predominant Irritable Bowel Syndrome research study

What is the primary objective of this study?

The investigators will evaluate the efficacy of soy dietary fiber in adults with diarrhea predominant irritable bowel syndrome.

Who is eligible to participate?

Inclusion Criteria: - willing to consent/undergo necessary procedures - between the age of 19 and 75 years - diarrhea predominant irritable bowel syndrome (satisfied with Rome II criteria) Exclusion Criteria: - uncontrolled hypertension (Blood pressure > 170/100 mmHg) - uncontrolled diabetes mellitus (FBS > 180 mg/dL) - malignancy, cerebrovascular disease, cardiovascular disease - history of abdominal surgery except appendectomy and hernia repair - inflammatory bowel disease - clinically or laboratory-confirmed gastroenteritis - the use of motility drug or dietary fiber supplement in 2 weeks - allergy to soy fiber - serum Cr > 2 x Upper normal limit - AST or ALT > 2 x Upper normal limit - Pregnancy, Lactating woman

Which medical condition, disease, disorder, syndrome, illness, or injury is researched?

Diarrhea Predominant Irritable Bowel Syndrome

Study Interventions

Interventions can include giving participants drugs, medical devices, procedures, vaccines, and other products that are either investigational or already available or noninvasive approaches such as surveys, education, and interviews.

Dietary Supplement:Soy Dietary FiberSoy Dietary Fiber, Once a day, before meal, 1 pack(20g), per oral with water 90mL

Dietary Supplement:Rice powderRice powder, Once a day, before meal, 1 pack(20g), per oral with water 90mL

Study Arms

Research studies and clinical trials typically have two or more research arms. An arm is a group of people who receive the same treatment in the study.

Soy Dietary Fiber

Rice powder

Study Status

Unknown status

Start Date: July 2011

Completed Date: July 2012

Phase: N/A

Type: Interventional

Design:

Primary Outcome: sum of irritable bowel syndrome symptom score

Secondary Outcome: irritable bowel syndrome symptom score

Study sponsors, principal investigator, and references

Principal Investigator: Joo Sung Kim, M.D., PhD

Lead Sponsor: Seoul National University Hospital

Collaborator:

More information:https://clinicaltrials.gov/show/NCT01373034

Discuss Irritability